| Literature DB >> 34165415 |
Atif Ali Khan Khalil1, Asma Saleem Qazi1, Abdul Nasir2, Mi-Jeong Ahn3, Muhammad Ajmal Shah4, Muhammad Saad Ahmad1, Wasim Sajjad1, Tahir Ali5, Muhammad Naeem1, Fawad Ali Shah6, Muhammad Tufail Ahmed Khan7, Muhammad Romman8, Adnan Haider1, Raishma Noor9.
Abstract
Natural products have been the focus of biomedical and pharmaceutical research to develop new therapies in recent years. 2-methoxy-6-acetyl-7-methyljuglone (2-methoxystypandrone, MAM) a natural bioactive juglone derivative, is known to have various levels of pharmacotherapeutic efficacies as an anti-inflammatory, anticancer, antioxidant, antimicrobial, and anti-HIV activities. MAM fights cancer progression by inducing apoptosis, necroptosis and deregulating signaling pathways through H2O2-induced JNK/iNOS/NO and MAPK, ERK1/2 pathways, JNK activation, and the RIP1/RIP3 complex. In this review, we summarize the pharmacological importance of MAM in the field of drug discovery. Furthermore, this review not only emphasizes the medicinal properties of MAM, but also discusses its potential efficacy in future medicinal products. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: 2-Methoxy-6-acetyl-7-methyljuglone; MAPK; anti-inflammatory; antibacterial; anticancer; antioxidant
Mesh:
Substances:
Year: 2022 PMID: 34165415 DOI: 10.2174/1871520621666210623095636
Source DB: PubMed Journal: Anticancer Agents Med Chem ISSN: 1871-5206 Impact factor: 2.505